Follow
Jaganathan K. Semburakkiannan
Jaganathan K. Semburakkiannan
Dy. Director
Verified email at seruminstitute.com
Title
Cited by
Cited by
Year
Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally
KS Jaganathan, SP Vyas
Vaccine 24 (19), 4201-4211, 2006
2442006
Development and characterization of surface modified PLGA nanoparticles for nasal vaccine delivery: effect of mucoadhesive coating on antigen uptake and immune adjuvant activity
D Pawar, S Mangal, R Goswami, KS Jaganathan
European Journal of Pharmaceutics and Biopharmaceutics 85 (3), 550-559, 2013
1532013
Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly (D, L-lactic-co-glycolic acid) versus chitosan microspheres
KS Jaganathan, YUB Rao, P Singh, D Prabakaran, S Gupta, A Jain, ...
International journal of pharmaceutics 294 (1-2), 23-32, 2005
1302005
Aerosolized liposome-based delivery of amphotericin B to alveolar macrophages
SP Vyas, S Quraishi, S Gupta, KS Jaganathan
International journal of pharmaceutics 296 (1-2), 12-25, 2005
1212005
Cholera toxin B subunit conjugated bile salt stabilized vesicles (bilosomes) for oral immunization
P Singh, D Prabakaran, S Jain, V Mishra, KS Jaganathan, SP Vyas
International journal of pharmaceutics 278 (2), 379-390, 2004
962004
Modified push–pull osmotic system for simultaneous delivery of theophylline and salbutamol: development and in vitro characterization
D Prabakaran, P Singh, P Kanaujia, KS Jaganathan, A Rawat, SP Vyas
International Journal of Pharmaceutics 284 (1-2), 95-108, 2004
912004
Mucoadhesive glycol chitosan nanoparticles for intranasal delivery of hepatitis B vaccine: enhancement of mucosal and systemic immune response
D Pawar, KS Jaganathan
Drug delivery 23 (1), 185-194, 2016
902016
Osmotically regulated asymmetric capsular systems for simultaneous sustained delivery of anti-tubercular drugs
D Prabakaran, P Singh, KS Jaganathan, SP Vyas
Journal of controlled release 95 (2), 239-248, 2004
872004
Methods of detecting cervical cancer
K Duraisamy, KS Jaganathan, JC Bose
Advances in Biological Research 5 (4), 226-232, 2011
722011
Comparison of humoral and cell-mediated immune responses to cationic PLGA microspheres containing recombinant hepatitis B antigen
V Saini, V Jain, MS Sudheesh, KS Jaganathan, PK Murthy, DV Kohli
International journal of pharmaceutics 408 (1-2), 50-57, 2011
702011
Development of a single-dose stabilized poly (D, L-lactic-co-glycolic acid) microspheres-based vaccine against hepatitis B
KS Jaganathan, P Singh, D Prabakaran, V Mishra, SP Vyas
Journal of pharmacy and pharmacology 56 (10), 1243-1250, 2004
702004
Nasal vaccine delivery
M Ramvikas, M Arumugam, SR Chakrabarti, KS Jaganathan
Micro and nanotechnology in vaccine development, 279-301, 2017
602017
Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system (s) administered intranasally
S Mangal, D Pawar, NK Garg, AK Jain, SP Vyas, DSVR Rao, ...
Vaccine 29 (31), 4953-4962, 2011
562011
Phylogenetic considerations in designing a broadly protective multimeric L2 vaccine
S Jagu, K Kwak, JT Schiller, DR Lowy, H Kleanthous, K Kalnin, C Wang, ...
Journal of virology 87 (11), 6127-6136, 2013
342013
Formulation and in-vitro evaluation of bilayer floating tablets of Metformin hydrochloride and Sitagliptin phosphate
GH Kumar, K Jaganathan, RS Kumar, P Perumal
International Journal of Advanced Pharmaceutics 2 (2), 64-81, 2012
252012
Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly (l-lactide …
V Saini, V Jain, MS Sudheesh, S Dixit, RL Gaur, MK Sahoo, SK Joseph, ...
Journal of drug targeting 18 (3), 212-222, 2010
202010
Evaluation of mucoadhesive nanoparticle based nasal vaccine
D Krishnakumar, D Kalaiyarasi, JC Bose, KS Jaganathan
Journal of Pharmaceutical Investigation 42 (6), 315-326, 2012
182012
Controlled porosity osmotic pumps of highly aqueous soluble drug containing hydrophilic polymers as release retardants
D Prabakaran, P Singh, P Kanaujia, V Mishra, KS Jaganathan, SP Vyas
Pharmaceutical development and technology 9 (4), 435-442, 2005
162005
Formulation and evaluation of cedrus deodara loud extract
P Shivanand, D Viral, G Manish, V Subhash, K Jaganathan
Int J Chem Tech Res 100, 1145-1152, 2009
152009
Method development and validation of HPLC tandem/mass spectrometry for quantification of perindopril arginine and amlodipine besylate combination in bulk and pharmaceutical …
K Duraisamy, KS Jaganathan
Research in Pharmaceutical Sciences 12 (4), 307-314, 2017
142017
The system can't perform the operation now. Try again later.
Articles 1–20